Perspectives
Nature Reviews Cancer 8, 555-563 (July 2008) | doi:10.1038/nrc2418
Science and society: Banking on cord blood stem cells
See also: | Correspondence by Nietfeld | Correspondence by Harris | Author's Reply by Sullivan | Correspondence by Patrinos |
Michael J. Sullivan1 About the author
Abstract
Umbilical cord blood gifted to non-profit public cord blood banks is now routinely used as an alternative source of haematopoietic stem cells for allogeneic transplantation for children and adults with cancer, bone marrow failure syndromes, haemoglobinopathies and many genetic metabolic disorders. Because of the success and outcomes of public cord banking, many companies now provide private cord banking services. However, in the absence of any published transplant evidence to support autologous and non-directed family banking, commercial cord banks currently offer a superfluous service.
Author affiliations
-
Michael J. Sullivan is at the Children's Cancer Research Group, and Children's Haematology Oncology Centre, Department of Paediatrics, Christchurch School of Medicine, University of Otago, 2 Riccarton Ave, Christchurch, 8005, New Zealand.
Email: michael.sullivan@otago.ac.nz
Published online 12 June 2008
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Touching baseNature Genetics News and Views (01 Nov 2000)
Placental blood transplant: Who will benefit?Nature Medicine News and Views (01 Sep 1996)
RESEARCH
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I?II clinical trialBone Marrow Transplantation Original Article
Patents versus transplantsNature Correspondence (11 Jul 1996)
See all 58 matches for Research